S'abonner

Clinical features of pyoderma gangrenosum and current diagnostic trends - 10/08/11

Doi : 10.1016/j.jaad.2010.01.049 
Ahmed Hadi, BA a, , Mark Lebwohl, MD b
a New York University School of Medicine, New York, New York 
b Department of Dermatology, Mount Sinai School of Medicine, New York, New York 

Reprint requests: Ahmed Hadi, BA, New York University School of Medicine, 435 E 30 St, RH-618, New York, NY 10016.

Abstract

Background

The diagnosis of pyoderma gangrenosum (PG) can be exceedingly difficult, and misdiagnosis can potentially yield serious consequences. Clinical criteria for establishing a reliable diagnosis have been previously proposed, but a consensus in their application has yet to be reached.

Objective

We sought to review recent trends in diagnosing PG and compare them with previously suggested diagnostic criteria.

Methods

Data for this article were obtained by searching the PubMed database using the key words “pyoderma gangrenosum.” Our search was limited to adult case reports that appeared in the English-language literature and received a final diagnosis of PG. The full text of the latest published 30 case reports that fulfilled these search criteria was reviewed. The articles spanned the years 2008 and 2009. Clinical features that appeared in the case descriptions were summarized and compared with the diagnostic criteria for the disease that were previously proposed.

Results

Of the 30 case reports, 16 described ulcers involving one or both legs, whereas only one case had peristomal involvement. Although 8 cases were associated with inflammatory bowel disease, 11 of the 30 patients did not have a systemic comorbidity. Fifteen lesions were noted to manifest at sites of trauma, which ranged from surgical incision sites to prolonged seatbelt compression. Nine case reports mentioned an undermined border in their clinical description, whereas only 5 authors commented on pustules and 6 described a purulent discharge. Only two authors commented on cribriform scarring.

Limitations

We only reviewed the latest published 30 case reports. Case series, which may have shown more typical cases, were excluded.

Conclusion

Currently, there is an underemphasis of clinical features in the diagnosis of PG, which can potentially lead to overdiagnosis. Establishing firm clinical criteria for diagnosing PG will ensure that case reports describe the same disease. This has implications in optimizing treatment strategies and improving patient outcomes.

Le texte complet de cet article est disponible en PDF.

Key words : autoimmune, dermatosis, gangrenosum, neutrophilic, pyoderma, ulcer


Plan


 Funding sources: None.
 Conflicts of interest: None declared.
 Disclosure: Dr Lebwohl has been a consultant for Abbott, Amgen, Astellas, Centocor, Genentech, UCB Pharma, Stiefel, Triax, Pharmaderm, Medicis, Novartis, and Warner Chilcott. He has been a speaker for Abbott, Amgen, Astellas, Centocor, and Genentech. Mr Hadi has no conflicts of interest to declare.


© 2010  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 64 - N° 5

P. 950 - mai 2011 Retour au numéro
Article précédent Article précédent
  • A review of phototherapy protocols for psoriasis treatment
  • Whitney Lapolla, Brad A. Yentzer, Jerry Bagel, Christian R. Halvorson, Steven R. Feldman
| Article suivant Article suivant
  • Holistic approach to treatment of intractable central neuropathic itch
  • Ashley R. Curtis, Charles Tegeler, Jonathan Burdette, Gil Yosipovitch

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.